How safe are asexual blood-stage malaria vaccines?

International Journal for Parasitology

Volumn 27, Issue 4, 1997, Pages 449-451

  Ferreira, Marcelo Urbano ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE;

ANIMAL; ARTICLE; HUMAN; IMMUNOLOGY; PLASMODIUM FALCIPARUM;

ANIMALS; HUMANS; MALARIA VACCINES; PLASMODIUM FALCIPARUM;

EID: 0031112145     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(96)00195-6     Document Type: Note

References (29)

1. Alonso P. L., Smith T., Armstrong-Schellenberg J. R. M., Masanja H., Mwankusye S., Urassa H., Bastos de Azevedo I., Chongela J., Kobero S., Menendez C., Hurt N., Thomas M. C., Lyimo E., Weiss N. A., Hayes R., Kitua A. Y., Lopez M. C., Kilama W. L., Teuscher T. & Tanner M. 1994. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344: 1175-1181.
2. Alonso P. L., Smith T. A., Armstrong-Schellenberg J. R. M., Kitua A. Y., Masanja H., Hayes R., Hurt N., Font F., Menendez C., Kilama W. L. & Tanner M. 1996. Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum. Journal of Infectious Diseases 174: 367-372.
3. Amador R. & Patarroyo M. E. 1996. Malaria vaccines. Journal of Clinical Immunology 16: 183-189.
4. Bouharoun-Tayoun H. & Druilhe P. 1992. P. falciparum malaria: evidence for an isotype imbalance which may be responsible for the delayed acquisition of protective immunity. Infection and Immunity 60: 1473-1481.
5. Bouharoun-Tayoun H., Oeuvray C., Lunel F. & Druilhe P. 1995. Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages. Journal of Experimental Medicine 182: 409-418.
6. Bouharoun-Tayoun H., Attanath P., Sabchareon A., Chongsuphajaisiddhi T. & Druilhe P. 1990. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. Journal of Experimental Medicine 172: 1633-1641.
7. D'Alessandro U. 1995. Malaria vaccine in children under 12 months of age-author's reply. Lancet 346: 1554-1555.
8. D'Alessandro U., Leach A., Drakeley C. J., Bennet S., Olaleye B. O., Fegan G. W., Jawara M., Langerock P., George M. O., Targett G. A. T. & Greenwood B. M. 1995. Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet 346: 462-467.
9. Das B. K., Parida S. & Ravindran B. 1996. A prognostic role for anti-phosphatidyl choline antibodies in human cerebral malaria. Clinical and Experimental Immunology 103: 442-445.
10. Ferreira M. U. 1996. Malaria vaccine trials: the missing qualitative data. Immunology and Cell Biology 74: 301-305.
11. Ferreira M. U., Kimura E. A. S., Souza J. M. & Katzin A. M. 1996. The isotype composition and avidity of naturally acquired anti-Plasmodium falciparum antibodies: differential patterns in clinically immune Africans and Amazonian patients. American Journal of Tropical Medicine and Hygiene 55: 315-323.
12. Ferreira M. U., Kimura E. S., Camargo L. M. A., Alexandre C. O. P., Pereira da Silva L. H. & Katzin A. M. 1994. Antibody response against Plasmodium falciparum exoantigens and somatic antigens: a longitudinal survey in a rural community in Rondonia, Western Brazilian Amazon. Acta Tropica 57: 35-46.
13. Groux H. & Gysin J. 1990. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Research in Immunology 141: 529-542.
14. Groux H., Perraut R., Garraud O., Poingt J. P. & Gysin J. 1990. Functional characterization of the antibody-mediated protection against blood stages of Plasmodium falciparum in the monkey Saimiri sciureus. European Journal of Immunology 20: 2317-2323.
15. Gysin J., Gravoille S., Mattei D., Scherf A., Bonnefoy S., Mercereau-Puijalon O., Feldman T., Muller-Hill B. & Pereira da Silva L. 1993. In vitro phagocytosis inhibition assay for the screening of potential candidate antigens for subunit vaccines against the asexual blood stage of Plasmodium falciparum. Journal of Immunological Methods 159: 209-219.
16. Holder A. A. & Riley E. M. 1996. Human immune response to MSP-1. Parasitology Today 12: 173-174.
17. Leach A., Drakeley C. J., D'Alessandro U., Fegan G. W., Bennet S., Ballou W. R., Targett G. A. T. & Greenwood B. M. 1995. A pilot safety and immunogenicity study of the malaria vaccine SPf66 in Gambian infants. Parasite Immunology 17: 441-444.
18. Malik-Peiris J. S., Premawansa S., Ranawaka M. B. R., Udagama P. V., Munasinghe Y. D., Nanayakkana M. V., Gamage C. P., Carter R., David P. H. & Mendis K. N. 1988. Monoclonal and polyclonal antibodies both block and enhance transmission of human Plasmodium vivax malaria. American Journal of Tropical Medicine and Hygiene 39: 26-32.
19. Mattei D., Scherf A., Bensaunde O. & Pereira da Silva L. 1989. A heat shock-like protein from the human malaria parasite Plasmodium falciparum induces autoantibodies. European Journal of Immunology 19: 1823-1828.
20. Nosten F., Luxemburger C., Kyle D. E., Ballou W. R., Wittes J., Wah E., Chongsuphajaisiddhi T., Gordon D. M., White N. J., Sadoff J. C., Heppner D. G. & the Shoklo SPf66 Malaria Vaccine Trial Group. 1996. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Lancet 348, 701-707.
21. O'Dea K. P., McKean P. G., Jarra W. & Brown K. N. 1996. A single gene copy merozoite surface antigen and immune evasion?. Parasite Immunology 18: 165-172.
22. Osiowy C., Horne D. & Anderson R. 1994. Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants. Clinical and Diagnostic Laboratory Immunology 1: 670-677.
23. Perraut R., Mercereau-Puijalon O., Mattei D., Bourreau E., Garraud O., Bonnemains B., Pereira da Silva L. & Michel J.-C. 1995. Induction of opsonizing antibodyes after injection of recombinant Plasmodium falciparum vaccine candidate antigens in preimmune Saimiri sciureus monkeys. Infection and Immunity 63: 554-562.
24. Schwartz D. H. 1994. Potential pitfalls on the road to an effective HIV vaccine. Immunology Today 15: 54-57.
25. Staprans S. I., Hamilton B. L., Follansbee S. E., Elbeik T., Barbosa P., Grant R. M. & Feinsberg M. B. 1995. Activation of virus replication after vaccination of HIV1-infected individuals. Journal of Experimental Medicine 182: 1727-1737.
26. Targett G. A. T. 1995. Malaria vaccines - now and the future. Transactions of the Royal Society of Tropical Medicine and Hygiene 89: 585-587.
27. Valero M. V., Amador R., Galindo C., Figueroa J., Bello M. S., Murillo L. A., Mora A. L., Patarroyo G., Rocha C. L., Rojas M., Aponte J. J., Sarmiento L. E., Lozada D. M., Coronell C. G., Ortega N. M., Rosas J. E., Alonso P. L. & Patarroyo M. E. 1993. Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia. Lancet 341: 705-710.
28. Wahlgren M., Berzins K., Perlmann P. & Persson M. 1983. Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of antiP. falciparum antibodies in different sera. Clinical and Experimental Immunology 54: 135-142.
29. Wilson C. F., Anand R., Clark J. T. & McBride J. S. 1987. Topography of epitopes on a polymorphic schizont antigen of Plasmodium falciparum determined by binding of monoclonal antibodies in a two-site radioimmunoassay. Parasite Immunology 9; 737-746.